BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 25830650)

  • 1. Impact of daptomycin resistance on Staphylococcus aureus virulence.
    Cameron DR; Mortin LI; Rubio A; Mylonakis E; Moellering RC; Eliopoulos GM; Peleg AY
    Virulence; 2015; 6(2):127-31. PubMed ID: 25830650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic and genotypic correlates of daptomycin-resistant methicillin-susceptible Staphylococcus aureus clinical isolates.
    Kang KM; Mishra NN; Park KT; Lee GY; Park YH; Bayer AS; Yang SJ
    J Microbiol; 2017 Feb; 55(2):153-159. PubMed ID: 28120188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gain-of-Function Mutations in the Phospholipid Flippase MprF Confer Specific Daptomycin Resistance.
    Ernst CM; Slavetinsky CJ; Kuhn S; Hauser JN; Nega M; Mishra NN; Gekeler C; Bayer AS; Peschel A
    mBio; 2018 Dec; 9(6):. PubMed ID: 30563904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causal role of single nucleotide polymorphisms within the mprF gene of Staphylococcus aureus in daptomycin resistance.
    Yang SJ; Mishra NN; Rubio A; Bayer AS
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5658-64. PubMed ID: 24002096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and Distribution of Single-Nucleotide Polymorphisms within mprF in Methicillin-Resistant Staphylococcus aureus Clinical Isolates and Their Role in Cross-Resistance to Daptomycin and Host Defense Antimicrobial Peptides.
    Bayer AS; Mishra NN; Chen L; Kreiswirth BN; Rubio A; Yang SJ
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4930-7. PubMed ID: 26055370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Multiple Single-Nucleotide Polymorphisms Within mprF on Daptomycin Resistance in Staphylococcus aureus.
    Yang SJ; Mishra NN; Kang KM; Lee GY; Park JH; Bayer AS
    Microb Drug Resist; 2018 Oct; 24(8):1075-1081. PubMed ID: 29381428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA).
    Thitiananpakorn K; Aiba Y; Tan XE; Watanabe S; Kiga K; Sato'o Y; Boonsiri T; Li FY; Sasahara T; Taki Y; Azam AH; Zhang Y; Cui L
    Sci Rep; 2020 Sep; 10(1):16107. PubMed ID: 32999359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of compensatory mutations associated with restoration of daptomycin-susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus and the role mprF mutations.
    Kanesaka I; Fujisaki S; Aiba Y; Watanabe S; Mikawa T; Katsuse AK; Takahashi H; Cui L; Kobayashi I
    J Infect Chemother; 2019 Jan; 25(1):1-5. PubMed ID: 30322736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of mprF sequences in methicillin-resistant Staphylococcus aureus clinical isolates: role in cross-resistance between daptomycin and host defense antimicrobial peptides.
    Bayer AS; Mishra NN; Sakoulas G; Nonejuie P; Nast CC; Pogliano J; Chen KT; Ellison SN; Yeaman MR; Yang SJ
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7462-7. PubMed ID: 25288091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of daptomycin resistance in daptomycin-naïve rabbits with methicillin-resistant Staphylococcus aureus prosthetic joint infection is associated with resistance to host defense cationic peptides and mprF polymorphisms.
    Mishra NN; Yang SJ; Chen L; Muller C; Saleh-Mghir A; Kuhn S; Peschel A; Yeaman MR; Nast CC; Kreiswirth BN; Crémieux AC; Bayer AS
    PLoS One; 2013; 8(8):e71151. PubMed ID: 23990934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of mprF in daptomycin-nonsusceptible Staphylococcus aureus strains.
    Yang SJ; Xiong YQ; Dunman PM; Schrenzel J; François P; Peschel A; Bayer AS
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2636-7. PubMed ID: 19289517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VraSR two-component regulatory system contributes to mprF-mediated decreased susceptibility to daptomycin in in vivo-selected clinical strains of methicillin-resistant Staphylococcus aureus.
    Mehta S; Cuirolo AX; Plata KB; Riosa S; Silverman JA; Rubio A; Rosato RR; Rosato AE
    Antimicrob Agents Chemother; 2012 Jan; 56(1):92-102. PubMed ID: 21986832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VraSR and Virulence Trait Modulation during Daptomycin Resistance in Methicillin-Resistant
    Taglialegna A; Varela MC; Rosato RR; Rosato AE
    mSphere; 2019 Feb; 4(1):. PubMed ID: 30760612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of in-vitro-selected daptomycin-non-susceptibility in Staphylococcus aureus.
    Patel D; Husain M; Vidaillac C; Steed ME; Rybak MJ; Seo SM; Kaatz GW
    Int J Antimicrob Agents; 2011 Nov; 38(5):442-6. PubMed ID: 21840181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LC-MS/MS characterization of phospholipid content in daptomycin-susceptible and -resistant isolates of Staphylococcus aureus with mutations in mprF.
    Rubio A; Moore J; Varoglu M; Conrad M; Chu M; Shaw W; Silverman JA
    Mol Membr Biol; 2012 Feb; 29(1):1-8. PubMed ID: 22276671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged Exposure to β-Lactam Antibiotics Reestablishes Susceptibility of Daptomycin-Nonsusceptible Staphylococcus aureus to Daptomycin.
    Jenson RE; Baines SL; Howden BP; Mishra NN; Farah S; Lew C; Berti AD; Shukla SK; Bayer AS; Rose WE
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32601160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of
    Jiang S; Zhuang H; Zhu F; Wei X; Zhang J; Sun L; Ji S; Wang H; Wu D; Zhao F; Yan R; Yu Y; Chen Y
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0129521. PubMed ID: 34662187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-genome sequencing identifies MprF mutations in a genetically diverse population of daptomycin non-susceptible Staphylococcus aureus in Australia.
    Lim C; Coombs GW; Daley DA; Shoby P; Mowlaboccus S
    Int J Antimicrob Agents; 2024 May; 63(5):107144. PubMed ID: 38494147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of genetic changes associated with daptomycin nonsusceptibility in Staphylococcus aureus.
    Ma Z; Lasek-Nesselquist E; Lu J; Schneider R; Shah R; Oliva G; Pata J; McDonough K; Pai MP; Rose WE; Sakoulas G; Malik M
    PLoS One; 2018; 13(6):e0198366. PubMed ID: 29879195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased cell wall teichoic acid production and D-alanylation are common phenotypes among daptomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates.
    Bertsche U; Yang SJ; Kuehner D; Wanner S; Mishra NN; Roth T; Nega M; Schneider A; Mayer C; Grau T; Bayer AS; Weidenmaier C
    PLoS One; 2013; 8(6):e67398. PubMed ID: 23785522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.